Please login to the form below

Not currently logged in
Email:
Password:

Ian Weatherhead joins Ipsen

Takes up corporate communications role at the French pharma firm

Ipsen Dr Ian WeatherheadFrench biopharmaceutical company Ipsen has appointed Ian Weatherhead as vice president, corporate external communications.

He brings 20 years of corporate communications experience within the life sciences sector, most recently at Teva UK/Ireland where he led its corporate communications and government affairs team.

Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.

In his new role at Ipsen Weatherhead will be responsible for the design and implementation of an external corporate communications strategy.

Reporting to senior vice president, public affairs and

corporate communications Didier Veron, Weatherhead will also oversee Ipsen’s media and public relations, digital communications, and corporate image and reputation.

Veron said: “I am delighted that Ian is joining the team to advance our external communications strategy as Ipsen continues its evolution into a leading global biopharmaceutical company focused on innovation and specialty care. He brings a wealth of experience in the pharmaceutical sector.”

13th September 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics